13 14 15 key words: Bacillus thuringiensis; Vip3A; biological control; 3D-structure; mode of 16 action; glycobiology 17 2 Abstract 39 The vegetative insecticidal proteins (Vips) secreted by Bacillus thuringiensis are 40 regarded as the new generation of insecticidal toxins because they have 41 different insecticidal properties compared with commonly applied insecticidal 42 crystal proteins (Cry toxins). Vip3A toxin, representing the vast majority of Vips, 43 has been used commercially in transgenic crops and bio-insecticides. However, 44 the lack of both structural information of Vip3A and a clear understanding of its 45 insecticidal mechanism at the molecular level, limits its further development and 46 broader application. Here we present the first crystal structure of the Vip3A toxin 47 in an activated form. Since all members of this insecticidal protein family are 48 highly conserved, the structure of Vip3A provides unique insight into the general 49 domain architecture and protein fold of the Vip3 family of insecticidal toxins. Our 50 structural analysis reveals a four-domain organization, featuring a potential 51 membrane insertion region, a receptor binding domain, and two glycan binding 52 domains of activated Vip3A. We further identify the specific glycan moieties 53 recognized by Vip3A through a glycan array screen. Taken together, these 54 findings provide insights into the mode of action of Vip3 family of insecticidal 55 toxins, and will boost the development of Vip3 into more efficient bio-56 insecticides. 57 58 59 60 61 62 63 64 3
The entomopathogenic bacteria Bacillus thuringiensis (Bt), is the most widely used microbial 66 insecticide in the world 1, 2 . It is renowned for its ability to produce insecticidal crystal proteins 67 (Cry toxins) during its sporulation phase, which have been widely used in the prevention and 68 control of agricultural pests through the development of transgenic plants or Bt-based 69 biopesticides 3-5 . However, many pests are not sensitive to Cry toxins, and the development of 70 insect resistance to Cry toxins has also been reported 1, [6] [7] [8] . The successful application of the Cry 71 proteins, coupled with their limitations, has spurred on intensive research seeking to identify 72 and characterize novel classes of insecticidal toxins that can be developed for agricultural 73
purposes. 74
Vegetative insecticidal proteins (Vips), which are produced by Bt during its vegetative 75 stages, have a wide spectrum of insecticidal activity, especially against lepidopteran pests 9 . To 76 date, ~150 distinct Vip toxins have been identified, which have been classified into four families 77 (Vip1, Vip2, Vip3 and Vip4) based on their sequence similarity 10 . Among the Vip toxin family, 78
Vip3A toxins are the most abundant and most studied 9 . Compared with known Cry toxins, 79
Vip3A toxins share no sequence homology, bind to different receptors [11] [12] [13] [14] , and lack cross-80 resistance [15] [16] [17] [18] , therefore they are considered as ideal options to complement and expand the use 81 of Bt in crop protection and resistance management. At present, the Vip3Aa toxin is the only 82 family member that has been used in commercial transgenic crops together with Cry toxins, 83 and no field-evolved resistance has yet been reported 1, 9, 19 . However, the lack of structural 84 information and incomplete understanding of its mechanisms of action have severely limited 85 the further development of Vip3A as a tool in pest control. 86 4 Vip3A toxins are large proteins (~800 amino acids) consisting of a conserved N-87 terminus and a variable C-terminal region. The ~89kDa Vip3A protoxin could be digested by 88 insect midgut juices into two fragments: a ~20 kDa fragment corresponding to the N-terminal 89 198 amino acids, and a ~66 kDa fragment corresponding to the rest of Vip3A protein and 90 carrying the toxic activity, which is considered to be the toxic core 9, 11, [20] [21] [22] [23] [24] [25] . This processing step 91 is regarded as an essential step for its activation and toxicity 11, 20, 21, [26] [27] [28] . Since their discovery 92 in 1996 29 , Vip3A proteins have been the subject of intensive research. It has been reported that 93
Vip3A stimulates membrane pore formation and apoptosis upon binding to target cells, which 94 is proposed to be responsible for its cytotoxic effects 11, 30, 31 . The scavenger receptor class C like 95 protein (Sf-SR-C) and the fibroblast growth factor receptor (Fgfr) have been reported as 96 potential receptors for Vip3A 13, 14 . However, although some in silico modeling efforts and low 97 resolution cryo-EM structures have attempted to obtain structural insight for these toxins, the 98 atomic structure of Vip3A is still not available, which makes it difficult to reveal the relationship 99 between their structure and function 27, 28, 32, 33 . 100
Here, we report the crystal structure of the toxic core of Vip3Aa. The structure shows 101 a four-domain organization which is likely to be conserved for the toxic core of all insecticidal 102 Vip3 family toxins. We identify conserved hydrophobic α-helices in domain Ⅱ, which we 103 predict to be involved in the membrane insertion process that follows the activation of cell-104 bound toxin. Structure-guided cell binding assays reveal that domain III is central to host cell 105 targeting and binding of Vip3A toxins. Structural analysis and glycan array studies indicate that 106
Vip3A toxins can recognize specific glycan moieties through domains Ⅳ and Ⅴ. Together, our 107 structural and functional studies provide new insights into the molecular mechanisms 108 5 underlying mode of action of insecticidal Vip3 toxins. 109
Results 110
Overall structure of Vip3Aa11 200-end 111
We used a Vip3A toxin from Bt strain C9, which has been named Vip3Aa11 (GenBank 112 accession No. AY489126.1) in this study. Full-length Vip3Aa11 consists of 789 amino acids, 113 which has been demonstrated to be digested between residues K198 and D199 by insect midgut 114 juice 20, 26, 27 . Of the two resulting fragments, the C-terminal fragment (D199 to end) is 115 considered to be the toxic core of Vip3A. 116
We started our crystallization trial with both Vip3Aa11 protoxin and Vip3Aa11 toxic 117 core. Using spare matrix crystallization screening, we only identified one condition that yielded 118 needle-shaped crystals of Vip3Aa11 protoxin. However, the crystals diffracted to only ~15 Å 119 and could not be improved despite extensive effort. No crystals were observed for the Vip3Aa 120 toxic core construct despite screening more than 1000 crystallization conditions. However, 121 when we deleted the N-terminal amino acid (Asp199) from the Vip3Aa11 toxic core, we 122 obtained the crystal of Vip3Aa11 200-end , which diffracted to ~6 Å. Through the addition of an N-123 terminal MBP (Maltose Bind Protein) tag, we were able to isolate crystals with improved 124
diffraction. 125
The final structure of Vip3Aa11 200-end was refined to a 3.2 Å resolution with R and R free 126 values to 0.1980 and 0.2389, respectively (Supplementary Table1) . The crystal belongs to the 127 P2 1 space group and four MBP-Vip3Aa11 molecules were found in one asymmetric unit 128 ( Supplementary Fig. 1 ). These four molecules form two dimers in different orientations. PISA 34 129 6 determined that there was limited interaction between two dimers, indicating that their 130 association was caused by the crystal packing ( Supplementary Fig. 1 ). Notably, the two 131 Vip3Aa11 molecules in the "dimer" showed moderate conformational variations, with a core 132 root mean square deviation (r.m.s.d) of 1.234 Å among 468 Cα atoms ( Supplementary Fig. 2) . 133
Superimposition of separate domains between the two molecules revealed better alignment for 134 domains Ⅲ, Ⅳ and Ⅴ, but not for domain Ⅱ ( Supplementary Fig. 2 ), suggesting that domain Ⅱ 135 might potentially be involved in the conformational changes during the activation of Vip3A 136 toxins. However, the result of gel filtration chromatography showed that MBP-Vip3Aa11 200-end 137 mainly exists as a monomer in solution ( Supplementary Fig. 3 ), which is consistent with 138 observations from a previous study 21 . Therefore, we used the monomeric structure of MBP-139 Vip3Aa11 200-end for subsequent analysis. 140
Our structure shows that the Vip3Aa11 toxic core is comprised of four domains( Fig.  141 1a and b). Therefore, the protoxin can be divided into five domains, starting from N-terminus: 142 domain Ⅰ, 1-198; domain Ⅱ, 199-327; domain Ⅲ, 327-518; domain Ⅳ, 537-667; and domain 143 Ⅴ, 679-789 in Vip3Aa11 ( Fig. 1a and Supplementary Fig. 4 ). The overall structure of the 144 Vip3Aa11 toxic core resembles a lobster, wherein domains Ⅱ and Ⅲ form the body, and 145 domains Ⅳ and Ⅴ are the claws of the lobster (Fig. 1b and c) . The connection between domain 146 Ⅱ and domain Ⅲ is compact. However, domains Ⅲ/IV and Ⅳ/Ⅴ are connected by long and 147 flexible loops, which indicates that the relative locations and orientations of these two domains 148 could change under different biological circumstances. There are over 100 known proteins of 149 the Vip3 family. Based on their high degree of sequence conservation and previous studies 9, 20, 150 26, 27 , they are very likely to share similar overall structures and domain compositions. Domain Ⅱ of Vip3Aa11 (residues199-327) consists of five helices, which form two layers ( Fig.  154 2a). The outer layer facing the solution contains two short helices, α2 and α3, while the inner 155 layer that contacts domain Ⅲ consists of three anti-parallel helices α1, α4 and α5. The outer 156 layer contacts with the upper portion of the inner layer and is almost perpendicular to the inner 157
layer. An intensive search against the PDB (Protein Data Bank) through the DALI server 35 158 failed to identify any known structure that shows significant homology with all five α-helices 159 of the domain Ⅱ from Vip3Aa11, suggesting that this is a novel protein fold. 160
Among these five helices, helix α4 is the longest one. It spans around 45 Å and contains 161 30 amino acid residues, starting from E267 at the N-terminus to L296 at the C-terminus. 162
Electrostatic surface potentials analysis shows that the majority of charged and polar amino 163 acid residues locate at N-terminal and C-terminal ends of helix α4 (Fig. 2b ). For the middle 164 portion of helix α4, from F274 to L289, 75% amino acid residues are hydrophobic residues. 165
Sequence alignment through Vip3 family shows that the hydrophobic region of helix α4 is very 166 much conserved and it is also the most agminated hydrophobic region of Vip3 family proteins 167 ( Supplementary Fig. 4 ). Close to helix α4, helix α1 also shows several conserved hydrophobic 168 amino acid residues facing to helix α4 ( Supplementary Fig. 4 and 5). Although these two α-169 helices are not directly connected in domain Ⅱ of Vip3A, this structural feature is very similar 170 to the hydrophobic helical hairpin from typical colicin fold, which has been shown to be 171 involved in membrane insertion of several α-pore-forming toxins 36 .
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Based on the sequence alignment, all the conserved amino acid residues were 173 highlighted on the Vip3Aa11 toxic core structure ( Fig. 2c ). It also shows that domain Ⅱ is the 174 most conserved domain compared to other domains. Electrostatic surface potentials analysis 175
shows that there is an obvious hydrophobic surface, which is mainly contributed by the 176 conserved helix α1 and α4 ( Fig. 2d) . 177
This similarity, the strong conservation of this hydrophobic patch and previous data 178 demonstrating the membrane insertion properties of Vip3A toxins 13 collectively suggest that 179 domain II is involved in the membrane insertion processes thought to be triggered once Vip3A 180 binding to host cell receptors. 181
Domain Ⅲ is involved in receptor binding of Vip3A toxin 182
Domain Ⅲ of Vip3Aa11 (residues 328-518) consists of twelve β strands and one short α-helix 183 at the C-terminal end (Fig. 3a ). Twelve β strands comprise three antiparallel β sheets sharing a 184 similar "Greek-key" topology ( Fig. 3a ) with a hydrophobic center featuring highly conserved 185 residues V349, F360, I362 and L370 from β sheet Ⅰ, I425 and F427 from β sheet Ⅱ and I481, 186 F492 and L505 from β sheet Ⅲ (Fig. 3b ). The results from DALI server 35 showed that the fold 187 of domain Ⅲ is similar to that of domain Ⅱ of the Cry family of insecticidal toxins, which has 188 been shown to be involved in host cell receptor recognition and binding 4 . We therefore sought 189 to explore whether domain III serves as a receptor binding domain for Vip3A toxins. 190
To explore this hypothesis, we used Spodoptera frugiperda cells (Sf9 cells and Sf21 191 cells), which have previously shown to be specifically targeted by Vip3 toxins 14, 37 . To determine 192 which domain(s) of Vip3Aa11 interact with Sf9 cells, we carried out fluorescence-based cell interaction of domain III alone with Sf9 cells is significantly stronger than that of the domain 198 I-II construct, indicating that domain III is central to Vip3A receptor binding to Sf9 cells. 199
Domains Ⅳ and Ⅴ are glycan binding motifs 200
Domains Ⅳ and Ⅴ both are all β sheets folds ( Fig. 4a and b ). Unlike domains Ⅱ and Ⅲ, which 201 have compact organization, domains Ⅲ/IV and Ⅳ/Ⅴ are connected by long and flexible loops 202 ( Fig. 4a ). In addition to these loops, there are several polar interactions between domains Ⅳ/Ⅴ 203 and domain Ⅲ, that reduce the flexibility and fix the domains Ⅳ and Ⅴ at the observed positions 204 and orientations (Fig. 4a) . 205
Domains Ⅳ and Ⅴ are both built from two anti-parallel sheets of β sandwich, forming 206 the "jelly-roll" topology. Despite showing only 17% sequence identity ( Fig. 4c ), domains Ⅳ 207 and V align very well structurally, with a root-mean-squared deviation (r.m.s.d) of 1.299Å over 208 61 Cα atoms ( Fig. 4d ). To examine the potential function of these two domains, we searched 209 for their structural homologues using the DALI sever 35 . The results for both domains show a 210 very high similarity (Z score>10) to family 16 carbohydrate binding module (CBM16) of S-211
Layer associated multidomain endoglucanase (RCSB ID 2ZEY). Superimposition of domains 212 Ⅳ, Ⅴ and CBM16 demonstrates that these three motifs share a similar fold (Fig 4e) , suggesting 213 that they likely share a related function as well. CBM16 is a carbohydrate-binding domain of 214 10 the highly active mannanase from the thermophile Thermoanaerobacterium 215 polysaccharolyticum with high specificity toward β1,4-glucose or β1,4-mannose polymers 38 . 216
Analysis of the electrostatic surface potential shows that both domains IV and V have a surface 217 pocket at a similar position to a sugar-binding pocket of the CBM16 domain, although all three 218 pockets have different shapes and charge distributions (Fig. 5a ). Taken together, our structural 219 analysis indicates that domains IV and V of Vip3A both contain a conserved glycan binding 220 motif and that these motifs may target different sugars. 221
In order to investigate the glycan binding properties of Vip3Aa11, we conducted 222 glycan array screening with purified biotin-labelled, full-length Vip3Aa11. Screening results 223
revealed that Vip3Aa11 has a strong binding preference to chitosan (GlcNβ1-4GlcN, 224
Chitobiose and GlcNβ1-4GlcNβ1-4GlcN, Chitotriose) and chitin (GlcNAcβ1-4GlcNAcβ1-225 4GlcNAc, Triacetyl chitotriose) ( Fig. 5b and Supplementary Table 2 ). Chitin is a major 226 structural component of the peritrophic matrix (PM), an extracellular envelope that surrounds 227 the midgut of most insects 39 . Epithelial cells in the midgut of insects synthesize chitin as a 228 homopolymer of β-(1,4)-N-acetyl-D-glucosamine (GlcNAc), which may be subsequently 229 converted to chitosan (a homopolymer of GlcN) by chitin deacetylase (CDA) secreted by insect 230 midgut cells 40 . The identification of chitin and chitosan as targets of Vip3Aa is therefore 231 consistent with previous studies that this toxin demonstrates specificity for binding insect 232 midgut cells 25, 41 . It also gives a potential explanation that why domains IV and V could not 233 bind to the sf9 cells which are from ovarian tissue and may lack of chitin and chitosan 39, 40 . In 234 addition to chitin and chitosan, the glycan array results revealed that Vip3Aa binds Lacto-N-235 tetraose as well as several monosaccharides including 6-deoxy-hexose, D-Fucose, L-Fucose 236 11 and L-Rhamnose (Fig. 5b) . Further studies will be required to determine the physiological 237 relevance of Vip3A's glycan binding specificities. 238
Discussion

239
Vip3A toxins show a wide spectrum of specific insecticidal activities and are functionally 240 distinct compared to the Cry toxins. These features makes them good candidates for combined 241 application with Cry toxins in transgenic crops to broaden the insecticidal spectrum and to 242 prevent or delay resistance 1, 9, 14 . The structural features and insecticidal mechanisms of Cry 243 toxins have been studied in detail, which has been crucial to their widespread application [2] [3] [4] [5] [6] 19 . 244
However, despite of the fact that Vip3 toxins were identified almost 25 years ago 29 , their mode 245 of action remains poorly understood. One of the main reasons for this is the lack of a high-246
resolution three-dimensional structure, which significantly impedes detailed molecular level 247 functional and mechanistic studies and thus limits the development of their insecticidal 248 potential. Accordingly, many groups have made great efforts to obtain or predict the atomic 249 structure of Vip3A 21, 27, 28, 32, 33 . However, high-resolution crystal structure of Vip3 toxin family 250 is still missing. In this study, we report the first crystal structure of the Vip3A toxin, which 251 provides a badly-needed framework to explore the molecular-level functional details of Vip3-252 family toxins. 253
Although the amino acid sequence similarity between the Vip3 family toxin and the 254 three domain Cry family (3d-Cry) toxin is very low, our three-dimensional structural analysis 255 showed interesting convergent evolution between these two families. Domain Ⅱ of Vip3 has an 256 all α-helix fold, including two conserved hydrophobic α-helices. Similarly, domain Ⅰ of 3d-Cry 257 also has an all α-helix fold and two hydrophobic α-helices, although it has additional α helices 258 surrounding the conserved hydrophobic helices 4, 42 . Several studies have reported that domain 259 Ⅰ of 3d-Cry toxin is involved in its membrane insertion and pore formation processes through 260 its conserved hydrophobic α-helices 4, 43-45 . This therefore suggests that domain Ⅱ of Vip3 may 261 also take part in these processes through its conserved hydrophobic α-helices. This is further 262 supported by the fact that the insertion of the typical colicin fold, a hydrophobic helical hairpin, 263
into the inner bacterial membrane is a minimal requirement for the pore formation of the pore-264 forming colicins 36 . 265
Both domain Ⅲ of Vip3 and domain Ⅱ of 3d-Cry are comprised of three β sheets with 266 a conserved hydrophobic core. Extensive studies on domain Ⅱ of 3d-Cry toxins showed that it 267 plays a key role in the recognition of midgut receptors. The results of our cell binding assay 268 indicate that Vip3 domain III is also central to cell binding. However, the receptor binding 269 specificity of Vip3 toxins is still unclear and requires further studies. 270
Domain Ⅲ of 3d-Cry toxins was predicted to bind glycans with a classic glycan 271 binding motif [46] [47] [48] [49] . Based on the amino acid sequence analysis, previous studies also predicted 272 that all Vip3A proteins contain a carbohydrate-binding motif (CBM_4_9 superfamily; 273 pfam02018) in the C-terminus (amino acids 536 to 652 in Vip3Aa) 9 . The function of this glycan 274 binding domain is not yet clear 9 . In the present structure, we found that instead of the single 275 CBM found in Cry toxins, there were two different CBM domains in the C-terminus of the Vip3 276 toxin, forming domains Ⅳ and Ⅴ respectively. Our structural analysis indicates that the putative 277 glycan-binding pockets of these two domains differ significantly, suggesting that they are likely 278 13 to have different glycan binding specificities. This multiplicity of CBMs in Vip3 toxins may 279 increase the diversity of their target polysaccharides. Interestingly, our glycan array results 280 indicate that Vip3Aa is able to bind both chitin (and the related chitosan) as well as a spectrum 281 of different monosaccharides. It is tempting to speculate that each of these two classes of 282 glycans is specifically recognized by one of Vip3's two glycan-binding domains. 283
In conclusion, we find here that although the overall structure and domain organization 284 are very different between Vip3 toxin and 3d-Cry toxin, these two families are comprised of 285 functionally and structurally related modules that are assembled in different ways, which may 286 expand the insecticidal spectrum of Bt and make Bt more powerful and efficient to target and 287 kill their hosts. 288
During the preparation of this manuscript, Zheng et al. reported the crystal structure of 289 full-length Vip3B2160 protein 50 , which shares around 60% sequence identity to Vip3A. The 290 overall structure of Vip3B2160 showed a five-domain organization (Fig. 6a) . The domain Ⅰ of 291 Vip3B2160 (the pro-toxin domain cleaved to produce the active core that we have crystalized 292 here) formed a unique fold containing five α-helices wrapping around Domain II (Fig. 6a) . 293
When these two Vip3 protein structures are superposed, domains Ⅲ, Ⅳ and Ⅴ of Vip3B2160 294 have very similar folds and organization with their counterparts from Vip3Aa11, respectively 295 ( Supplementary Fig. 7) . However, there are dramatic differences in their domain II 296 conformations, especially for the helices α1 and α2 (Fig. 6b ). In Vip3B structure, similar to 297 classic pore-forming toxin colicin A 36 , the highly conserved hydrophobic α-helix 298 (corresponding to the helix α4 in Vip3A domain II) is surrounded by other helices from domains 299 14 Ⅰ and Ⅱ. We hypothesize that this structural difference in domain II between the full-length and 300 cleaved Vip3 proteins may represent the conformational change that switches this toxin from 301 "inactive" to "active". In this scenario, once domain I is cleaved by insect midgut juice, the α-302 helices of domain Ⅱ undergo a dramatic structural shift that enables helix α1 to rotate to form 303 a hairpin-like structure with helix α4. This new conformation, which strongly resembles the 304 colicin A-type membrane insertion fold, represents the active membrane insertion moiety of 305
Vip3 toxins (Fig. 6c) . In a word, our crystal structure of Vip3A toxic core, combined with the 306 structure of full-length Vip3B, reveals that the cleavage between domain I and domain II of 307
Vip3 toxin, and the further conformational changes of domain II are essential steps for Vip3's 308 activation and function. 309
In summary, we report here the first crystal structure of Vip3A toxic core. It revealed 310 the general domain organization of Vip3 family toxin and the potential function of each domain. 311
Our study confirmed the glycan binding ability and defined the specificity of the Vip3A toxin 312 using a glycan array screen. Importantly, we identify a conserved colicin A-type membrane 313 insertion fold in the active core of our Vip3A structure which, through a structural comparison 314 with full-length (inactive) Vip3B, enabled us to propose an activation mechanism for the Vip3 315 family toxins. Collectively, these data provide important structural and functional insights into 316
Vip3 family toxins as well as a valuable resource to guide future studies and to re-evaluate the 317 previous genetic and functional studies that will be crucial for the development of respectively. All plasmids were generated by the Gibson assembly strategy 51 . The nucleotide 335 sequences of recombinant plasmid were verified by DNA sequencing. All the primers used in 336 this study are shown in Supplementary Table 3 . 337
Protein expression and purification 338
Native His-MBP-Vip3Aa 200-end (Vip3Aa 200-end ) protein was expressed in E. coli B21(DE3) at 339 25°C for 48h in autoinduction Terrific broth (TB) medium. The cells were harvested by 340 centrifugation at 5000×g at 4 °C for 15 min and the pellet was resuspended in lysis buffer (20 341 mM Tris-HCl pH 8 and 150 mM NaCl). After the cells were lysed by high pressure cell crusher 342 16 (Union-Biotech co,.LTD) , the supernatant was collected after centrifuged at 12,000×g at 4 °C 343 for 60 min. The proteins were purified using Ni-NTA agarose resin ( 
Crystallization and data collection 359
The purification of His 6 -tagged MBP-Vip3Aa 200-end used for crystallization is described above. A native data set with the space group of P2 1 2 1 2 1 was collected at 3.62 Å (native I). A weak 367 selenomethionine (SeMet) derivative data set was collected at 3.9 Å with the same symmetry 368 as the native I crystal for the amino-acid assignment using the difference Fourier map of the 369 SeMet derivative. After further crystallization optimization, another native crystal (native II) 370 was obtained with the space group of P2 1 that could diffract to around 3.2 Å. Diffraction data 371 were collected on BL17U1 and BL18U beamlines at Shanghai Synchrotron Radiation Facility 372 (Shanghai, China) and processed by HKL2000 52 . 373
Structural determination and refinement 374
Molecular replacement was carried out to identity the MBP positions in the native crystals by 375 PHASER 53 . The initial phases were further improved with the multi-crystal averaging 54 . Model 376 building was performed manually in COOT 55 , and the sequence assignment was helped with 377 the SeMet anomalous difference map. Figures were prepared using PyMol (v.2.3.2, 378 https://pymol.org/). Structure refinement was done by PHENIX 56 . The data collection and 379 refinement statistics are summarized in Supplementary Table 1 . 380
Glycan microarray analysis 381
Purified full-length Vip3Aa protein were labelled with EZ-Link NHS-LC-LC-Biotin reagent in 382 20 mM HEPES pH 8.0 and 100 mM NaCl with a 4:1 molar excess of biotin. Unreacted biotin 383 was removed by dialysis, and the resulting protein was concentrated by Amicon Ultra 384 centrifugal filter (Millipore). The sample was diluted to 2.5 μg/ml and analyzed on a glycan 385 100 binding array provided by Creative Biochip. The reaction buffer was used as the negative 386 18 control and the streptavidin was used as the positive control. The signals were measured in 387 microarray scanner (LuxScan-10K/A; CapitalBio). The mean signal representing one glycan 388 probe is the average of signals from triplicate spots on a single glycan array and compared by 389 one-way ANOVA with Dunnett's multiple comparisons test. All assays were repeated at least 390 three times. 391
Immunofluorescence 392
Sf9 cells with a density of 5 × 10 4 cells per ml were seeded into 6-well culture plates separately. 393
After overnight culture, the cells were respectively treated with RFP tagged Vip3Aa or its 394 truncations (0.15 μM) for 6 h. After treatment, the cells were washed three times with PBS to 395 remove unbound proteins, and fixed with 4% paraformaldehyde at 37 ˚C for 15 min. The cell 396 nuclei were labeled with DAPI (0.2 μg/ml) for 30 min. Cell images were captured using a Nikon. 397
TI-E inverted fluorescence Microscope. 398 399
Statistical analysis 400
All functional assays were performed at least three times independently. Data were shown as 401 means ± SD. All statistical data were calculated using GraphPad Prism version 8.0. One-way 402 ANOVA followed by Dunnett's test were used to identify statistically significant differences 403 between treatments. Significance of mean comparison is annotated as follow: ns, not significant; 404 **, P<0.01; ***, P<0.001. A p value of < 0.05 was considered to be statistically significant. Dm Ⅱ Dm Ⅲ
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